Etrasimod- CAS 1206123-37-6

CAS No.: 1206123-37-6

Inquire Etrasimod (cas: 1206123-37-6 ) online by filling out the inquiry form, we will get back to you within 24 hours!

Etrasimod,1206123-37-6
Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I006736
Synonyms:

APD334; APD-334; APD 334; Etrasimod.;(R)-2-(7-((4-cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid

Molecular Formula:

C26H26F3NO3

Molecular Weight:457.5
Description:Etrasimod, also known as APD334, is a potent, centrally available, functional antagonists of the S1P1 receptor for use as next generation therapeutics for treating multiple sclerosis (MS) and other autoimmune diseases. APD334 has a favorable PK/PD profile, producing robust lymphocyte lowering at relatively low plasma concentrations in several preclinical species. APD334 was efficacious in a mouse experimental autoimmune encephalomyelitis (EAE) model of MS and a rat collagen induced arthritis (CIA) model and was found to have appreciable central exposure.
Price:Get quote

We would like to match the lowest price on market if possible.

Etrasimod, also known as APD334, is a potent, centrally available, functional antagonists of the S1P1 receptor for use as next generation therapeutics for treating multiple sclerosis (MS) and other autoimmune diseases. APD334 has a favorable PK/PD profile, producing robust lymphocyte lowering at relatively low plasma concentrations in several preclinical species. APD334 was efficacious in a mouse experimental autoimmune encephalomyelitis (EAE) model of MS and a rat collagen induced arthritis (CIA) model and was found to have appreciable central exposure.

Chem Calculators

© 2017-2022 MuseChem - A division of ArrakisTek Inc. All Rights Reserved.